Amantadine
How it works: Treating relapses and symptoms →
In development for MS or related diseases. No approval for these conditions is recorded in the bank.
- Molecule type
- Small molecule
Approvals
None recorded.
Safety communications
None recorded.
Trials
Key trials
Large trials with a reported result on their main goal.
- Amantadine, phase 3
Completed · Phase 3 · MS (type not specified) · Main goal met
- Amantadine, phase 3
Completed · Phase 3 · MS (type not specified) · Main goal not met
Other trials (4)
Completed small trials, dose-finding studies and trials in other diseases.
- FETEM
Status unknown · Phase 3 · MS (type not specified) · result_in_paper_unread
- Amantadine, phase 3
Completed · Phase 3 · MS (type not specified) · results_posted_no_test
- Amantadine, phase 2
Completed · Phase 2 · MS (type not specified) · Not an efficacy test
- ND
Completed · Phase 2 · MS (type not specified) · result_in_paper_unread
For information only, not medical advice. Talk to your neurologist before changing treatment.
Hypotheses involving this medicine
Loading hypotheses…
Loading reviews and guidelines…
Lab studies
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error